0.8872
price down icon3.04%   -0.0278
after-market After Hours: .87 -0.0172 -1.94%
loading
Sutro Biopharma Inc stock is traded at $0.8872, with a volume of 362.04K. It is down -3.04% in the last 24 hours and up +10.17% over the past month. Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
See More
Previous Close:
$0.915
Open:
$0.93
24h Volume:
362.04K
Relative Volume:
0.27
Market Cap:
$74.93M
Revenue:
$153.73M
Net Income/Loss:
$-106.79M
P/E Ratio:
-0.4984
EPS:
-1.78
Net Cash Flow:
$-115.93M
1W Performance:
+16.74%
1M Performance:
+10.17%
6M Performance:
-56.51%
1Y Performance:
-79.30%
1-Day Range:
Value
$0.8706
$0.9563
1-Week Range:
Value
$0.76
$1.01
52-Week Range:
Value
$0.5231
$5.17

Sutro Biopharma Inc Stock (STRO) Company Profile

Name
Name
Sutro Biopharma Inc
Name
Phone
650-392-8412
Name
Address
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Name
Employee
269
Name
Twitter
@SutroBio
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
STRO's Discussions on Twitter

Compare STRO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
STRO
Sutro Biopharma Inc
0.8872 77.28M 153.73M -106.79M -115.93M -1.78
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-16-25 Upgrade Piper Sandler Neutral → Overweight
Mar-17-25 Downgrade H.C. Wainwright Buy → Neutral
Mar-14-25 Downgrade BofA Securities Buy → Underperform
Mar-14-25 Downgrade Citizens JMP Mkt Outperform → Mkt Perform
Mar-14-25 Downgrade Wedbush Outperform → Neutral
May-08-24 Initiated BofA Securities Buy
Nov-09-23 Initiated Deutsche Bank Buy
Oct-06-23 Initiated Oppenheimer Outperform
Mar-21-23 Downgrade Wells Fargo Overweight → Equal Weight
Aug-18-22 Resumed Wells Fargo Overweight
Jun-18-21 Initiated H.C. Wainwright Buy
Dec-03-20 Initiated Stifel Buy
Sep-02-20 Initiated Jefferies Buy
Jul-16-20 Initiated Wells Fargo Overweight
Jan-13-20 Initiated SunTrust Buy
Oct-07-19 Initiated BTIG Research Buy
Jul-18-19 Initiated Deutsche Bank Buy
Apr-29-19 Initiated H.C. Wainwright Buy
Oct-22-18 Initiated JMP Securities Mkt Outperform
Oct-22-18 Initiated Piper Jaffray Overweight
Oct-22-18 Initiated Wedbush Outperform
View All

Sutro Biopharma Inc Stock (STRO) Latest News

pulisher
10:44 AM

What makes Sutro Biopharma Inc. stock price move sharplyGet timely alerts on market movers - jammulinksnews.com

10:44 AM
pulisher
06:20 AM

Key External Factors That Drive Sutro Biopharma Inc. Stock Price MovementsMomentum Buy Alert - Newser

06:20 AM
pulisher
06:14 AM

What are the technical indicators suggesting about Sutro Biopharma Inc.High-yield investments - jammulinksnews.com

06:14 AM
pulisher
05:01 AM

Why Sutro Biopharma Inc. stock attracts strong analyst attentionParabolic Move Ideas - Newser

05:01 AM
pulisher
Jul 25, 2025

What analysts say about Sutro Biopharma Inc. stockFree Capital Allocation Plans - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Sutro Biopharma Inc. Stock Analysis and ForecastFree Capital Growth Strategies - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

How Sutro Biopharma Inc. stock reacts to Fed policy changesUnrivaled growth potential - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 23, 2025

Here's Why Sutro Biopharma (NASDAQ:STRO) Must Use Its Cash Wisely - Yahoo Finance

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Sutro Biopharma Inc. stock priceExplosive capital gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Sutro Biopharma partners with FDA to develop ADC reference materials By Investing.com - Investing.com Canada

Jul 22, 2025
pulisher
Jul 22, 2025

Sutro Biopharma partners with FDA to develop ADC reference materials - Investing.com Australia

Jul 22, 2025
pulisher
Jul 22, 2025

Sutro Biopharma Announces Research Collaboration with the FDA to Advance Regulatory Standards for Antibody Drug Conjugates - The Manila Times

Jul 22, 2025
pulisher
Jul 22, 2025

FDA Selects Sutro Biopharma's Revolutionary Platform to Shape Future of Cancer Drug Development - Stock Titan

Jul 22, 2025
pulisher
Jul 20, 2025

Is Sutro Biopharma Inc. a good long term investmentBreakthrough financial growth - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 16, 2025

what makes sutro biopharma inc. stock price move sharplyReal Time Alert Service - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

How Sutro Biopharma Inc. stock performs during market volatilityMoney Making Low Risk Plans - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World

Jul 11, 2025
pulisher
Jul 10, 2025

Vontobel Holding Ltd. Has $33,000 Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Jul 10, 2025
pulisher
Jun 30, 2025

Sutro Biopharma, Inc.(NasdaqGM: STRO) dropped from Russell 2000 Dynamic Index - MarketScreener

Jun 30, 2025
pulisher
Jun 25, 2025

Sutro Biopharma Faces NASDAQ Non-Compliance Notice - TipRanks

Jun 25, 2025
pulisher
Jun 17, 2025

Sutro Biopharma (NASDAQ:STRO) Upgraded to Overweight at Piper Sandler - Defense World

Jun 17, 2025

Sutro Biopharma Inc Stock (STRO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Sutro Biopharma Inc Stock (STRO) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
FITZPATRICK LINDA A
CHIEF PEOPLE & COMM. OFFICER
May 01 '25
Option Exercise
0.00
37,849
0
133,282
Srinivasan Venkatesh
CHIEF TECH OP OFFICER
May 01 '25
Option Exercise
0.00
2,500
0
54,580
Borgman Anne Elizabeth
CHIEF MEDICAL OFFICER
May 01 '25
Option Exercise
0.00
69,063
0
122,161
Srinivasan Venkatesh
CHIEF TECH OP OFFICER
Apr 11 '25
Option Exercise
0.00
21,250
0
59,683
NEWELL WILLIAM J
CEO
Mar 05 '25
Option Exercise
0.00
18,750
0
299,239
FITZPATRICK LINDA A
CHIEF PEOPLE & COMM. OFFICER
Mar 05 '25
Option Exercise
0.00
8,750
0
99,027
ALBINI EDWARD C
CFO AND SECRETARY
Mar 05 '25
Option Exercise
0.00
8,750
0
135,675
FITZPATRICK LINDA A
CHIEF PEOPLE & COMM. OFFICER
Mar 04 '25
Option Exercise
0.00
9,125
0
94,025
NEWELL WILLIAM J
CEO
Mar 04 '25
Option Exercise
0.00
31,125
0
291,625
Chung Jane
PRESIDENT AND COO
Mar 04 '25
Option Exercise
0.00
7,875
0
100,642
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Cap:     |  Volume (24h):